Viread and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is reported as a side effect among people who take Viread (tenofovir disoproxil fumarate), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Furosemide, and have Cellulitis.

The phase IV clinical study analyzes which people have Fluid retention when taking Viread. It is created by eHealthMe based on reports of 51,434 people who have side effects when taking Viread from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,703 drugs and 2,443 conditions by eHealthMe. Check the latest studies of Fluid retention.

On Jul, 06, 2026

51,434 people reported to have side effects when taking Viread.
Among them, 17 people (0.03%) have Fluid retention.

Among these 17 people:

How long have people been on Viread when they have Fluid retention? *

What is the gender of people who have Fluid retention when taking Viread? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Fluid retention when taking Viread? *

What are other drugs people take besides Viread? *

What are other side effects people have besides Fluid retention? *

Acute Kidney Failure: 5 people, 29.41%
Fatigue (feeling of tiredness): 4 people, 23.53%
Hepatic Steatosis (fatty liver disease): 3 people, 17.65%
Renal Cyst (kidney cyst): 3 people, 17.65%
Hypokalemia (low potassium): 3 people, 17.65%
Muscle Spasms (muscle contraction): 3 people, 17.65%
Chronic Kidney Disease: 3 people, 17.65%
Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 3 people, 17.65%
Peripheral Swelling: 3 people, 17.65%
Urinary Tract Infection: 3 people, 17.65%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 11.76%
Cellulitis (infection under the skin): 2 people, 11.76%
Vitritis (inflammation of the vitreous humour of the eye): 1 person, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Retinitis (inflammation of the retina in the eye): 1 person, 5.88%
Nuclear Magnetic Resonance Imaging Brain: 1 person, 5.88%
Hepatomegaly (abnormal enlargement of the liver): 1 person, 5.88%
Hepatocellular Carcinoma (liver cancer): 1 person, 5.88%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 5.88%
Asthma: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viread:

Viread (51,542 reports)

Fluid retention treatments and more:

Fluid retention (79,660 reports)

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid retention:

Fluid retention (1,703 drugs)

Browse all the conditions that are associated with Fluid retention:

Fluid retention (2,443 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate (the active ingredients of Viread) and Viread (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.